The Proactive team is on the road next week as we stage events in Manchester and London.
Both are set to be highly exciting evenings, as we showcase a variety of firms with growth potential.
To ensure a place make sure you register HERE.
Fastnet Oil (LON:FAST) is making big waves in two of the oil and gas sector’s most promising exploration areas.
It owns 18.75% of Foum Assaka, a deep-water exploration licence off the coast of Morocco where BP took a stake through a farm-in deal with Fastnet's existing partner Kosmos.
The terms of the deal set a highly significant benchmark for Fastnet as it tries to find its own farm-out partner to cover its share of the drilling.
Meanwhile, talks to bring in a partner for its equally exciting assets in the Celtic Sea are ongoing with the aim to have this process concluded by the end of this year. Farm-out terms would likely involve a “significant” contribution to past costs, including 3D seismic and a contribution to a drilling programme anticipated in 2015.
Commercial director Christian Klinkenberg will join us to explain the potential of all of Fastnet's portfolio.
When we had Golden Saint Resources (AIM:GSR) at our London event this summer, executive chairman Cyril D' Silva revealed the group would be very quickly cash generative.
It is on the cusp of achieving this ambition having received its licence to export diamonds from Sierra Leone.
The plan initially is a very simple one: to buy rough diamonds from the country’s artisanal and small-scale miners and then cutting and polishing them. It’s a process that adds huge value to the stones, and provides a potentially huge return on the initial investment. But like the gemstones it plans to create, this is a multi-faceted business which also has significant gold assets in Sierra Leone. Giving us the lowdown is Cyril D'Silva.
In the current environment for gold, the most sought-after companies are those with a low and falling cost of production where output is rising.
Anglo Asian Mining (AIM:AAZ) hits those twin sweet spots.
A new agitation leach plant should bring costs down to a best-in-class US$450-US$500 an ounce, while the output from its new mine should push production up to 60,000 ounces and then 89-90,000 ounces, the company said recently.
Unfortunately Anglo has been hit by the stampede out of the sector, although it is only a matter of time before investors eventually cotton on to the opportunity. Here to tell us more is Reza Vaziri, CEO
Meanwhile, Dublin, Toronto and London-listed Falcon Oil & Gas (AIM,ESM, TSX-V:FOG) has had a super-charged year so far but that may just be the start for this exciting junior, which is brimming with potential.
The first half saw the company raise US$25million, achieve debt-free status and significantly reduce its operating loss.
It is now focused on securing a farm-out deal for its massive acreage at the Betaloo basin in Australia, which is shaping up to be a world-class conventional and unconventional oil and gas play and says discussions are "well advanced".
City Broker Cantor Fitzgerald has noted that Betaloo is one of the largest basins in Australia with consultant Ryder Scott estimating recoverable resources of 18bbbls and 64 tcf gas.
It reckons the group will have its “pick” of partners, with BG (LON:BG.), Statoil (ETR:DNQA), Total (EPA:FP) and ConocoPhilips (NYSE:COP) among the raft of new entrants into the Australian shale gas arena.
Joining us will be chief executive Philip O'Quigley.
Register for this event HERE.
Sphere Medical has achieved a landmark the leaves many rivals looking to commercialise their technology. It has landed a truly blue-chip partner whom it is hoped will take the group to that next level an on to success.
The name of the collaborator is Johnson & Johnson, best known here as the maker of cotton buds here in the UK, but a real powerhouse in the world of making and selling medical devices.
J&J arm OCD has no doubt been attracted by the fact that Sphere’s Proxima blood monitoring technology provides both economic and clinical benefits over the existing technology – a must in these straitened times for healthcare providers.
It will be interesting to see the market reaction when investors finally wake up to Sphere’s real potential.
InternetQ is a fast growing mobile marketing firm. That alone should be enough to grab investors’ attention. But it also has a well-established music streaming offering, Akazoo, that is going toe-to-toe with media darlings Spotify and Deezer.
Interim results released last month showed the firm’s cash flow turning positive, and that should give the firm the wherewithal to make more bolt-on acquisitions, such as the recent purchase of Atlas Interactive that bolstered the company’s presence in Germany.
The group’s focus on fast growing markets and the breakneck growth in the adoption of handheld communication devices – smartphones and tablets to you and me – should ensure that the group’s eye-catching level of organic growth will continue.
The shares are up almost 60% over the last year, but still only trade on an historic earnings multiple of around 17; strip out the €8.5mln or so of cash and the earnings multiple for this £125mln-valued company drops further.
Our next guests are coming all the way from Canada - bringing with them news of a ground-breaking medical device will help in the battle with heart disease.
VentriPoint Diagnostics has created an ultrasound diagnostic tool to monitor patients that provides a cost-effective and very accurate in measuring ventricle heart function.
Congenital heart disease in children will be its first application, although the VMS system can be used across many major heart conditions, including pulmonary hypertension, cardiovascular disease and heart failure.
So this is an innovation has multi-billion dollar market potential.
Canada and Europe have granted approval for the sale of the VMS, while the group has still win approval from America’s all-powerful Food & Drug Administration. Joining us to tell us more will be CEO, George Adams.
The increased popularity of computing on the move is behind the success of Globo, the enterprise mobility management and telecom software solutions provider.
IT departments across the world are – sometimes grudgingly – acquiescing to employees’ requests to hook their own mobile devices into their company’s enterprise software, and Globo is making this “bring your own device” (BYOD) trend a lot less painful the IT guys.
Whatever the operating system - Android, Apple’s IOS, Blackberry, Windows or even the still popular feature phones – Globo’s platform can integrate them all, meaning employees can access company information from anywhere in the world where their phone can get a signal.
Interim results in September showed scintillating growth rates: revenues up 52% and pre-tax profits up 74%. The company is determined to maintain its competitive edge, and recently tied up a North American distribution deal and struck partnerships with tech heavyweights IBM and Fujitsu.
Both events start at 6pm. Please join us at 5.45pm to allow for a prompt 6:00pm start.
Each company has approximately 30 minutes to give a short presentation and for Q&A. Followed by the 'Champagne Raffle' where 6 lucky guests will win a bottle each.
The evening will end with a complimentary bar and an assortment of the finest hot & cold canapes, giving you the opportunity to speak with the directors and other investors.